Is the Antiglobulin Test a Good Marker for Predicting the Development of Hemolytic Disease of the Newborn in ABO Incompatibility?

dc.contributor.authorAydin, Mustafa
dc.contributor.authorDeveci, Ugur
dc.contributor.authorOrman, Aysen
dc.contributor.authorTaskin, Erdal
dc.date.accessioned2026-08-12T17:32:53Z
dc.date.issued2016
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1016/j.pedneo.2015.11.006
dc.identifier.endpage449
dc.identifier.issn1875-9572
dc.identifier.issue5
dc.identifier.orcid0000-0003-1783-0185
dc.identifier.orcid0000-0002-5395-8250
dc.identifier.pmid27211278
dc.identifier.scopus2-s2.0-84975483736
dc.identifier.scopusqualityQ2
dc.identifier.startpage449
dc.identifier.urihttps://doi.org/10.1016/j.pedneo.2015.11.006
dc.identifier.urihttps://hdl.handle.net/11508/56814
dc.identifier.volume57
dc.identifier.wosWOS:000397546500018
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Taiwan
dc.relation.ispartofPediatrics and Neonatology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.titleIs the Antiglobulin Test a Good Marker for Predicting the Development of Hemolytic Disease of the Newborn in ABO Incompatibility?
dc.typeLetter

Dosyalar